AbbVie Logo

AbbVie

🇺🇸
ABBV
US00287Y1091

AbbVie is a global, research-based biopharmaceutical company from the US. It researches, develops, and delivers innovative therapies for some of the world's most complex and serious diseases. Focusing on immunology, oncology, and neuroscience, AbbVie improves patients' lives through scientific innovation and commitment.

Next Quarterly Earnings

Friday, October 30, 2026
CW 44
Pre-Market
In 17 days

Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

Currently in quiet period until October 30, 2026

Stock Price

Earnings preview

AbbVie (ABBV) will release its Q3 2026 earnings before market open on October 30, 2026. Analysts estimate an EPS of 3.84 USD and revenue of 17,312 million USD. In the last reported quarter (Q2 2026), the company reported an EPS of 3.65 USD, beating the estimate of 3.61 USD by 1.2%.

Generated automatically from our data — as of 10/10/2026

Recap: the latest results

AbbVie (ABBV) reported its Q2 2026 financial results on July 31, 2026, before market open. The company reported quarterly earnings per share (EPS) of 3.65 USD, beating the analyst estimate of 3.61 USD by 1.2%. Quarterly revenue reached 16990 million USD. Following the publication, the stock price fell by 2.51%.

Generated automatically from our data — as of 08/06/2026 Read the article →

Frequently asked questions

When will AbbVie report its next quarterly earnings?

AbbVie is scheduled to report its next quarterly earnings on 10/30/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).

When did AbbVie last report quarterly earnings?

AbbVie last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 3.65 USD.

How does AbbVie stock react to earnings?

Across its last 5 earnings reports, AbbVie stock moved by ±3.7% on average the following day. The largest reaction was +4.7% on 01/31/2025; 2 of 5 reactions were positive.

How often has AbbVie beaten expectations?

AbbVie has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the AbbVie earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:$3.84
Actual:—
Q2 2026
Beat
Estimate:$3.61
Actual:$3.65
Difference:+$0.04
Price reaction (1 day):-2.5 %
Price reaction (7 days):-4.4 %
Q1 2026
Beat
Estimate:$2.59
Actual:$2.65
Difference:+$0.06
Price reaction (1 day):+3.1 %
Price reaction (7 days):+3.7 %
Q4 2025
Beat
Estimate:$2.65
Actual:$2.71
Difference:+$0.06
Price reaction (1 day):-3.8 %
Price reaction (7 days):-2.1 %
Q3 2025
Beat
Estimate:$1.78
Actual:$1.86
Difference:+$0.08
Price reaction (1 day):-4.5 %
Price reaction (7 days):-4.0 %
Q1 2025
Beat
Estimate:$2.91
Actual:$2.97
Difference:+$0.06
Q4 2024
Estimate:—
Actual:—
Price reaction (1 day):+4.7 %
Price reaction (7 days):+8.5 %

Earnings statistics

Stock reaction to earnings

±3.7%
Avg. next-day move
+4.7%
Largest move (01/31/2025)
40%
Share of positive reactions
±4.5%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+1.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
AbbVie
Ticker Symbol
ABBV
ISIN
US00287Y1091
Country
🇺🇸
USA
Sector
More Financial Information